中國再生醫學(08158)收購康美贊55%股權 X
03/01/2026 01:24
<匯港通訊>   中國再生醫學(08158)宣布,全資附屬公司中再生(香港)與中國星(00326)全資附屬公司訂立一項買賣協議,據此,中再生同意以代價5500元,收購康美贊生物55%股權。

收購事項完成後,中再生(香港)及 China Star 將分別持有康美贊55%及45%股權。 (WH)



Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.